Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-260
Closed -$3.82K 3450
2025
Q3
$3.82K Sell
260
-80
-24% -$815 ﹤0.01% 1830
2025
Q2
$3.34K Buy
340
+150
+79% +$1.24K ﹤0.01% 1719
2025
Q1
$1.38K Buy
190
+55
+41% +$481 ﹤0.01% 2139
2024
Q4
$1.06K Buy
135
+25
+23% +$206 ﹤0.01% 2186
2024
Q3
$814 Buy
110
+65
+144% +$547 ﹤0.01% 2299
2024
Q2
$360 Buy
45
+35
+350% +$313 ﹤0.01% 2206
2024
Q1
$116 Buy
+10
New +$111 ﹤0.01% 2125

Other funds holding ETNB

Rothschild Investment LLC's ETNB Position: Q4 2025 in Review

Rothschild Investment LLC sold out of 89bio (ETNB) in Q4 2025, closing a stake of 260 shares — an estimated $3.82K sold.

Rothschild Investment LLC first reported a position in ETNB in Q1 2024 and held it in 7 quarters. The position peaked at $3.82K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Rothschild Investment LLC reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Rothschild Investment LLC sold 260 89bio shares in Q4 2025, an estimated $3.82K.
  • Rothschild Investment LLC first reported a position in 89bio in Q1 2024 and held it in 7 quarters.
  • Rothschild Investment LLC's 89bio position peaked at $3.82K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Rothschild Investment LLC's 13F filing for Q4 2025, filed 10 Feb 2026.